Lionel Tarassenko

Lionel Tarassenko, (born 17 April 1957) is a British engineer and academic, who is a leading expert in the application of signal processing and machine learning to healthcare. Tarassenko is President of Reuben College, Oxford.

He was previously Head of Department of Engineering Science (Dean of Engineering) at the University of Oxford, succeeded by Ronald A. Roy. Towards the end of his time as Dean, the Department rose to number 1 in the Times Higher Education World University Rankings.

Tarassenko was elected Professor of Electrical Engineering at the University of Oxford in 1997 and was a Professorial Fellow of St John's College, Oxford, from 1997 to 2019. In 2019 he was invited by the Vice-Chancellor Louise Richardson to oversee the development of Reuben College, the University's 39th college. He is also a Pro-Vice Chancellor and the Chair of the Management Committee of the Maison Française d’Oxford.

Tarassenko is the author of over 280 journal papers, 200 conference papers, 3 books and over 30 granted patents. He has supervised 65 doctoral students. He has been a founder director of four University spin-out companies, the latest being Oxehealth in September 2012. He was the R&D Director and Chair of the Strategic Advisory Board of Sensyne Health, an AIM-listed company from 2018 to 2022. He is a director of the University’s wholly owned Technology Transfer company, Oxford University Innovation. He was the editor-in-chief of the 2018 Topol Review of NHS Technology and its impact on the workforce.

Tarassenko was the driving force behind the creation of the Institute of Biomedical Engineering (IBME) at the University of Oxford, which he directed from its opening in April, 2008 to October, 2012. He established an £8m Centre of Excellence in Medical Engineering within the IBME, and led the Technology & Digital Health theme in the National Institute for Health and Care Research (NIHR) Oxford Biomedical Research Centre from its inception in 2007 until 2022. Under his leadership, the IBME grew from 110 to 220 academic researchers and it was awarded a Queen’s Anniversary Prize for Higher Education in 2015 for “new collaborations between engineering and medicine delivering benefit to patients”. Provided by Wikipedia